ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Adverse Events Decreased With Proton Chemoradiotherapy drugs
January 06, 2020Proton chemoradiotherapy is associated with a significantly lower risk for 90-day adverse events and a decrease in performance status during treatment compared with photon therapy, according to a study published online December in?JAMA Oncology.
Pharma Sources Insight January 2025
